CDC. Health Disparities. Healthy Youth. https://www.cdc.gov/healthyyouth/disparities/index.htm
• Magnan S. Social Determinants of Health 101 for Health Care. Natl Acad Med Perspect. Published online 2017:1–9. This perspective from the National Academy of Medicine reviews the social determinants of health and their importance on overall health and healthcare.
Social Determinants of Health. Healthy People - US Department of Health and Human Services. Published 2022. https://health.gov/healthypeople/objectives-and-data/social-determinants-health
Chukwueke UN, Hervey-Jumper S, Porter A. Disparities and inequities among patients with central nervous system tumor. Hematol Oncol Clin North Am. 2022;36(1):e1–8. https://doi.org/10.1016/j.hoc.2021.10.002.
• Porter AB, Chukwueke UN, Mammoser AG, Friday B, Hervey-Jumper S. Delivering equitable care to underserved neuro-oncology populations. Am Soc Clin Oncol Educ Book. 2021;41:38–46. https://doi.org/10.1200/edbk_320803. This review covers different ways to achieve health equity in neuro-oncology. Interventions include increasing diversity in clinical trials, increasing access to telemedicine and ways to optimize community practices, and provider education in bias, stereotyping, and racism.
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.
Ostrom QT, Price M, Neff C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019. Neuro-Oncol. 2022;24(5):v1–95. https://doi.org/10.1093/neuonc/noac202.
Article CAS PubMed PubMed Central Google Scholar
Plascak JJ, Fisher JL. Area-based socioeconomic position and adult glioma: a hierarchical analysis of surveillance epidemiology and end results data. PLoS ONE. 2013;8(4):e60910. https://doi.org/10.1371/journal.pone.0060910.
Article CAS PubMed PubMed Central Google Scholar
Poynter JN, Fonstad R, Tolar J, Spector LG, Ross JA. Incidence of intracranial germ cell tumors by race in the United States, 1992–2010. J Neurooncol. 2014;120(2):381–8. https://doi.org/10.1007/s11060-014-1562-7.
Article PubMed PubMed Central Google Scholar
• Jackson HN, Hadley CC, Khan AB, et al. Racial and socioeconomic disparities in patients with meningioma: a retrospective cohort study. Neurosurgery. 2022;90(1):114–23. https://doi.org/10.1227/NEU.0000000000001751. Retrospective analysis that showed that minority patients were more likely to present to the emergency department than to an outpatient clinic. Minority patients also had more advanced clinical symptoms at time of presentation and experienced longer postoperative stays.
Butterfield JT, Golzarian S, Johnson R, et al. Racial disparities in recommendations for surgical resection of primary brain tumours: a registry-based cohort analysis. Lancet Lond Engl. 2022;400(10368):2063–73. https://doi.org/10.1016/S0140-6736(22)00839-X.
Bhambhvani HP, Rodrigues AJ, Medress ZA, Hayden GM. Racial and socioeconomic correlates of treatment and survival among patients with meningioma: a population-based study. J Neurooncol. 2020;147(2):495–501. https://doi.org/10.1007/s11060-020-03455-2.
Sherwood PR, Dahman BA, Donovan HS, Mintz A, Given CW, Bradley CJ. Treatment disparities following the diagnosis of an astrocytoma. J Neurooncol. 2011;101(1):67–74. https://doi.org/10.1007/s11060-010-0223-8.
Rivera Perla KM, Tang OY, Durfey SNM, et al. Predicting access to postoperative treatment after glioblastoma resection: an analysis of neighborhood-level disadvantage using the area deprivation index (ADI). J Neurooncol. 2022;158(3):349–57. https://doi.org/10.1007/s11060-022-04020-9.
Burton E, Yusuf M, Gilbert MR, Gaskins J, Woo S. Failure to complete standard radiation therapy in glioblastoma patients: patterns from a national database with implications for survival and therapeutic decision making in older glioblastoma patients. J Geriatr Oncol. 2020;11(4):680–7. https://doi.org/10.1016/j.jgo.2019.08.014.
Ostrom QT, Krebs HL, Patil N, Cioffi G, Barnholtz-Sloan JS. Racial/ethnic disparities in treatment pattern and time to treatment for adults with glioblastoma in the US. J Neurooncol. 2021;152(3):603–15. https://doi.org/10.1007/s11060-021-03736-4.
Patel AM, Ali O, Kainthla R, et al. Primary central nervous system lymphoma: a real-world comparison of therapy access and outcomes by hospital setting. Neuro-Oncol Pract. 2022;9(3):183–92. https://doi.org/10.1093/nop/npab066.
Karsy M, Yoon N, Boettcher L, et al. Surgical treatment of glioblastoma in the elderly: the impact of complications. J Neurooncol. 2018;138(1):123–32. https://doi.org/10.1007/s11060-018-2777-9.
Gulati S, Jakola AS, Nerland US, Weber C, Solheim O. The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma. World Neurosurg. 2011;76(6):572–9. https://doi.org/10.1016/j.wneu.2011.06.014.
Mukherjee D, Patil CG, Todnem N, et al. Racial disparities in Medicaid patients after brain tumor surgery. J Clin Neurosci Off J Neurosurg Soc Australas. 2013;20(1):57–61. https://doi.org/10.1016/j.jocn.2012.05.014.
• Thomas G, Almeida ND, Mast G, et al. Racial disparities affecting postoperative outcomes after brain tumor resection. World Neurosurg. 2021;155:e665–73. https://doi.org/10.1016/j.wneu.2021.08.112. Minority patients have significantly higher rates of postoperative complications, including cardiovascular, pulmonary, and urinary issues. This leads to extended length of stay in comparison to Caucasian patients.
Hodges TR, Labak CM, Mahajan UV, et al. Impact of race on care, readmissions, and survival for patients with glioblastoma: an analysis of the National Cancer Database. Neuro-Oncol Adv. 2021;3(1):040. https://doi.org/10.1093/noajnl/vdab040.
Curry WT, Barker FG. Racial, ethnic and socioeconomic disparities in the treatment of brain tumors. J Neurooncol. 2009;93(1):25–39. https://doi.org/10.1007/s11060-009-9840-5.
Curry WTJ, Carter BS, Barker FGI. Racial, ethnic, and socioeconomic disparities in patient outcomes after craniotomy for tumor in adult patients in the United States, 1988–2004. Neurosurgery. 2010;66(3):427. https://doi.org/10.1227/01.NEU.0000365265.10141.8E.
Rouse C, Gittleman H, Ostrom QT, Kruchko C, Barnholtz-Sloan JS. Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010. Neuro-Oncol. 2016;18(1):70–7. https://doi.org/10.1093/neuonc/nov249.
Pulido JS, Vierkant RA, Olson JE, Abrey L, Schiff D, O’Neill BP. Racial differences in primary central nervous system lymphoma incidence and survival rates. Neuro-Oncol. 2009;11(3):318–22. https://doi.org/10.1215/15228517-2008-103.
Article PubMed PubMed Central Google Scholar
Vaughn JL, Epperla N. Racial disparities in the survival of patients with primary central nervous system lymphoma in the United States, 2000–2019. Blood. 2022;140(1):13182–3. https://doi.org/10.1182/blood-2022-170762.
Estevez-Ordonez D, Abdelrashid M, Coffee E, et al. Racial and socioeconomic disparities in glioblastoma outcomes: a single-center, retrospective cohort study. Cancer. n/a(n/a) https://doi.org/10.1002/cncr.34881
Mirpuri P, Singh M, Rovin RA. The association of preoperative frailty and neighborhood-level disadvantage with outcome in patients with newly diagnosed high grade glioma. World Neurosurg. 2022;166:e949–57. https://doi.org/10.1016/j.wneu.2022.07.138.
Bower A, Hsu FC, Weaver KE, et al. Community economic factors influence outcomes for patients with primary malignant glioma. Neuro-Oncol Pract. 2020;7(4):453–60. https://doi.org/10.1093/nop/npaa010.
Liu EK, Yu S, Sulman EP, Kurz SC. Racial and socioeconomic disparities differentially affect overall and cause-specific survival in glioblastoma. J Neurooncol. 2020;149(1):55–64. https://doi.org/10.1007/s11060-020-03572-y.
Nayak L, Lee EQ, Wen PY. Epidemiology of brain metastases. Curr Oncol Rep. 2012;14(1):48–54. https://doi.org/10.1007/s11912-011-0203-y.
Hatiboglu MA, Akdur K, Sawaya R. Neurosurgical management of patients with brain metastasis. Neurosurg Rev. 2020;43(2):483–95. https://doi.org/10.1007/s10143-018-1013-6.
Fecci PE, Champion CD, Hoj J, et al. The evolving modern management of brain metastasis. Clin Cancer Res Off J Am Assoc Cancer Res. 2019;25(22):6570–80. https://doi.org/10.1158/1078-0432.CCR-18-1624.
Virnig BA, Baxter NN, Habermann E, Feldman RD, Bradley CJ. A matter of race: early- versus late-stage cancer diagnosis. Health Aff Proj Hope. 2009;28(1):160–8. https://doi.org/10.1377/hlthaff.28.1.160.
Hall WJ, Chapman MV, Lee KM, et al. Implicit racial/ethnic bias among health care professionals and its influence on health care outcomes: a systematic review. Am J Public Health. 2015;105(12):e60–76. https://doi.org/10.2105/AJPH.2015.302903.
Article PubMed PubMed Central Google Scholar
Chapman EN, Kaatz A, Carnes M. Physicians and implicit bias: how doctors may unwittingly perpetuate health care disparities. J Gen Intern Med. 2013;28(11):1504–10. https://doi.org/10.1007/s11606-013-2441-1.
Article PubMed PubMed Central Google Scholar
Liu D, Schuchard H, Burston B, Yamashita T, Albert S. Interventions to reduce healthcare disparities in cancer screening among minority adults: a systematic review. J Racial Ethn Health Disparities. 2021;8(1):107–26. https://doi.org/10.1007/s40615-020-00763-1.
De la Garza RR, Benton JA, Gelfand Y, et al. Racial disparities in clinical presentation, type of intervention, and in-hospital outcomes of patients with metastatic spine disease: an analysis of 145,809 admissions in the United States. Cancer Epidemiol. 2020;68:101792. https://doi.org/10.1016/j.canep.2020.101792.
Comments (0)